RT @gcfmd: Did SPRINT patients in the intensive arm maintain SBP levels after the trial showed the benefits of dosing so? Nope Longer-Ter…
RT @JAMACardio: In a secondary analysis of SPRINT, the mortality benefits of intensive BP control attenuated after the trial, while outpati…
RT @gcfmd: Did SPRINT patients in the intensive arm maintain SBP levels after the trial showed the benefits of dosing so? Nope Longer-Ter…
RT @NMPajewski: Some new work from SPRINT, of the not unexpected, but disappointing variety. Not going to shock anyone, but for blood press…
RT @gcfmd: Did SPRINT patients in the intensive arm maintain SBP levels after the trial showed the benefits of dosing so? Nope Longer-Ter…
RT @NMPajewski: Some new work from SPRINT, of the not unexpected, but disappointing variety. Not going to shock anyone, but for blood press…
RT @jdmosqueral: Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control https://t.co/2GlN040MEt vía @JAMA…
RT @gcfmd: Did SPRINT patients in the intensive arm maintain SBP levels after the trial showed the benefits of dosing so? Nope Longer-Ter…
In @JAMACardio secondary analysis of #SPRINT for #longerterm f/u of intensive #BP control.🚫#CV or all cause mortality change. #BP actually went⬆️in f/u. #HTN can't be set it & forget it. Discuss w/patients. #Cardiotwitter #MedEd #hypertension Read mor
RT @byronjaeger1: New article in JAMA Cardio! We investigated the long-term effect of reducing systolic BP to <120 mm Hg for ~3 years on CV…
RT @medical_xpress: Study highlights importance of long-term management of #hypertension @JAMACardio https://t.co/DETntDlMLl https://t.co/u…
RT @medical_xpress: Study highlights importance of long-term management of #hypertension @JAMACardio https://t.co/DETntDlMLl https://t.co/u…
Study highlights importance of long-term management of #hypertension @JAMACardio https://t.co/DETntDlMLl https://t.co/uf4B3iSJqu
RT @gcfmd: Did SPRINT patients in the intensive arm maintain SBP levels after the trial showed the benefits of dosing so? Nope Longer-Ter…
RT @gcfmd: Did SPRINT patients in the intensive arm maintain SBP levels after the trial showed the benefits of dosing so? Nope Longer-Ter…
Great work by our own @WakeBDS @byronjaeger1 and @NMPajewski @WFCTSI @WFBMI!!! @JAMA_current @JAMACardio
RT @gcfmd: Did SPRINT patients in the intensive arm maintain SBP levels after the trial showed the benefits of dosing so? Nope Longer-Ter…
Did SPRINT patients in the intensive arm maintain SBP levels after the trial showed the benefits of dosing so? Nope Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control https://t.co/K8KInd4jAk via @JAMACardio part of @
Sustaining BP control to the Systolic Blood Pressure Intervention Trial target of 💥less than 120 mm Hg💥will be critical for achieving population reductions in cardiovascular mortality @BIHSoc_Events @PCCS_UK @Shahed__Ahmad @NHSEngland @TheBHF https://t.
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control https://t.co/2GlN040MEt vía @JAMACardio part of @JAMANetwork
RT @JAMACardio: In a secondary analysis of SPRINT, the mortality benefits of intensive BP control attenuated after the trial, while outpati…
Yes, benefit from lower SBP requires this to be sustained over time. These data should counter the pervasive therapeutic inertia and lead to more focus on SBP control at individual person and population levels.
RT @NMPajewski: Some new work from SPRINT, of the not unexpected, but disappointing variety. Not going to shock anyone, but for blood press…
"Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control" (JAMA Cardiology) - "Sustaining BP control to the SPRINT target of <120 mm Hg will be critical for achieving population reductions in cardiovascular mortality" -
RT @JAMACardio: In a secondary analysis of SPRINT, the mortality benefits of intensive BP control attenuated after the trial, while outpati…
RT @byronjaeger1: New article in JAMA Cardio! We investigated the long-term effect of reducing systolic BP to <120 mm Hg for ~3 years on CV…
Some new work from SPRINT, of the not unexpected, but disappointing variety. Not going to shock anyone, but for blood pressure control to provide benefit, you have to keep doing it. @byronjaeger1 @Aging_MD @adambress https://t.co/2Tm65aFRXZ
RT @JAMACardio: In a secondary analysis of SPRINT, the mortality benefits of intensive BP control attenuated after the trial, while outpati…
New article in JAMA Cardio! We investigated the long-term effect of reducing systolic BP to <120 mm Hg for ~3 years on CVD and all-cause mortality. Sadly, no evidence of long-term benefit, likely because maintaining BP control post-trial was a challenge
In a secondary analysis of SPRINT, the mortality benefits of intensive BP control attenuated after the trial, while outpatient systolic BP increased by an average of 7 mm Hg for participants in the intensive treatment group. https://t.co/INSo2zYzhp #Resear